The best smart scales for 2025

The New Year is here and there’s no better time to kickstart those health and fitness goals. Whether you’re looking to shed a few holiday pounds, track your muscle gains or simply stay on top of a [...]

How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race

Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant consistently led the pack in new prescriptions, becoming virtually synonymous w [...]

Eli Lilly's Zepbound beat Novo Nordisk’s Wegovy in a big weight loss drug study

Eli Lilly’s (LLY) and Novo Nordisk’s (NVO) weight loss drugs went head-to-head in a weight loss study for the first time — and Eli Lilly’s drug came out on top.Read more... [...]

Black Forest Labs launches Flux.2 AI image models to challenge Nano Banana Pro and Midjourney

It's not just Google's Gemini 3, Nano Banana Pro, and Anthropic's Claude Opus 4.5 we have to be thankful for this year around the Thanksgiving holiday here in the U.S.No, today the Germ [...]

Verdiva launches with $410M for weight loss drugs to challenge Ozempic, Wegovy

London-headquartered biotech startup Verdiva has emerged from stealth with a whopping $410mn for a new range of drugs aimed at tackling the obesity epidemic. It’s one of Europe’s largest-ever biot [...]

Cigna is raising its annual profit forecast on specialty drug strength

The health company now expects full-year adjusted earnings of at least $30.45 per share, up 10 cents from its prior outlook [...]

Stanford researchers will discuss their agentic 'scientists' that are on course to reshape drug discovery at VB Transform 2026

Drug discovery is notoriously inefficient. Pharmaceutical projects span years, moving from one specialized human team to the next through disconnected workflows that result in knowledge loss during ea [...]

AI models block 87% of single attacks, but just 8% when attackers persist

One malicious prompt gets blocked, while ten prompts get through. That gap defines the difference between passing benchmarks and withstanding real-world attacks — and it's a gap most enterprise [...]

Qwen 3.8-Max and Claude Opus 5 show why raw benchmark scores don't predict the bill

Alibaba released Qwen 3.8-Max this week and marketed the preview as second only to Claude Fable 5 (their launch-day table was more equivocal: the model leads on one of 12 coding-agent rows). But an in [...]